NeuroPace, Inc.
NASDAQ:NPCEMedical - Devices
+$0.05 today
- Market cap
- $283.19M
- Beta
- 1.88
- P/E (TTM)
- -23.8
- EPS (TTM)
- -$0.64
Volume 0.31M
Average 0.18M
NPCE Goodwill
The premium paid for acquisitions above the fair value of the identifiable net assets acquired.
NeuroPace, Inc.NASDAQ: NPCE
Goodwill · Q1 FY2026 · quarter ended Mar 2026
Goodwill remains negative
Q1 FY2026 goodwill was $0, compared with $0 a year earlier.
Context
- Goodwill amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Goodwill increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Goodwill history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Goodwill | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Goodwill vs competitors
How NPCE compares with its peers on the latest reported figures
- NPCE's Mar 2026 goodwill of $0 is the highest of the 2 companies compared; the peer median is $0.
- Goodwill amounts to 0.0% of total assets for NPCE, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
MOBIMobia Medical, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding NPCE) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for NPCE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 19.19M | 6.61M | 18.06M | 13.43M | 21.69M |
| Short-term Investments | 96.4M | 70.8M | 48.4M | 39.33M | 39.37M |
| Net Receivables | 7.09M | 7.48M | 12.31M | 12.85M | 14.68M |
| Inventory | 7.82M | 9.71M | 11.21M | 13.38M | 16.9M |
| Other Current Assets | 100K | 3.11M | 2.74M | 2.35M | 1.44M |
| Total Current Assets | 132.82M | 97.71M | 92.72M | 81.34M | 94.07M |
| Property, Plant & Equipment (Net) | 603K | 15.9M | 14.41M | 12.9M | 11.26M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 143K | 490K | 524K | 413K | 235K |
| Total Non-current Assets | 746K | 16.39M | 14.93M | 13.31M | 11.49M |
| Total Assets | 133.56M | 114.11M | 107.65M | 94.65M | 105.57M |
| Account Payables | 1.38M | 2.15M | 2.33M | 2.95M | 2.22M |
| Short-term Debt | 0 | 0 | 0 | 0 | 2.12M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 1.09M | 555K | 141K |
| Other Current Liabilities | 490K | 0 | 0 | 0 | 2.85M |
| Total Current Liabilities | 9.3M | 10.98M | 16.23M | 15.16M | 17.81M |
| Long-term Debt | 49.85M | 52.91M | 56.95M | 59.53M | 58.88M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 911K | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 50.76M | 68.35M | 70.77M | 71.48M | 68.72M |
| Total Liabilities | 60.06M | 79.33M | 87M | 86.63M | 86.53M |
| Common Stock | 24K | 25K | 28K | 30K | 34K |
| Retained Earnings | (423.77M) | (470.85M) | (503.81M) | (530.95M) | (552.42M) |
| Accumulated OCI | (272K) | (1.11M) | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 73.5M | 34.78M | 20.65M | 8.01M | 19.03M |
| Total Debt | 49.85M | 69.77M | 72.4M | 73.34M | 70.84M |
| Net Debt | 30.66M | 63.16M | 54.34M | 59.91M | 49.15M |
NeuroPace, Inc.
NASDAQ:NPCE
Intrinsic Alpha fair value
Locked
Current Price
$8.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.